speb/financial-data huggingface dataset:
VBIO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -5655000.00
VBIO cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: 0.00
VBIO income_statement (annual, 2024-12-31) — Net Interest Income: 6000.00
VBIO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
VBIO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 6000.00
VBIO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -49000.00
VBIO balance_sheet (annual, 2024-12-31) — Net PPE: 2000.00
VBIO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
VBIO cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2535000.00
VBIO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 49000.00
VBIO income_statement (annual, 2024-12-31) — Normalized EBITDA: -4118000.00
VBIO income_statement (annual, 2024-12-31) — Normalized Income: -4470000.00
VBIO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -5725000.00
VBIO income_statement (annual, 2024-12-31) — Operating Income: -4476000.00
VBIO income_statement (annual, 2024-12-31) — Operating Revenue: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 556977.00
VBIO balance_sheet (annual, 2024-12-31) — Other Current Assets: 240000.00
VBIO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 15000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 15000.00
VBIO income_statement (annual, 2024-12-31) — Other Gand A: 3163000.00
VBIO balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 117000.00
VBIO balance_sheet (annual, 2024-12-31) — Other Properties: 31000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Other Properties: 31000.00
VBIO balance_sheet (annual, 2024-12-31) — Payables: 125000.00
VBIO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 257000.00
VBIO balance_sheet (annual, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Preferred Securities Outside Stock Equity: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
VBIO cash_flow (annual, 2024-12-31) — Preferred Stock Issuance: 0.00
VBIO income_statement (annual, 2024-12-31) — Pretax Income: -4470000.00
VBIO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Properties: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
VBIO cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 354000.00
VBIO cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 338000.00
VBIO cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: 0.00
VBIO cash_flow (annual, 2024-12-31) — Purchase Of Investment: 0.00
VBIO cash_flow (annual, 2024-12-31) — Purchase Of PPE: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Raw Materials: 460000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Raw Materials: 460000.00
VBIO balance_sheet (annual, 2024-12-31) — Receivables: 69000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Receivables: 69000.00
VBIO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 778000.00
VBIO income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 419000.00
VBIO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 352000.00
VBIO income_statement (annual, 2024-12-31) — Research And Development: 1313000.00
VBIO balance_sheet (annual, 2024-12-31) — Retained Earnings: -43541000.00
VBIO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 1187000.00
VBIO income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: 241000.00
VBIO income_statement (annual, 2024-12-31) — Selling General And Administration: 3163000.00
VBIO balance_sheet (annual, 2024-12-31) — Share Issued: 556977.00
VBIO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 229000.00
VBIO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2535000.00
VBIO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2535000.00
VBIO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
VBIO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Total Assets: 2807000.00
VBIO balance_sheet (annual, 2024-12-31) — Total Capitalization: 2535000.00
VBIO balance_sheet (annual, 2024-12-31) — Total Debt: 0.00
VBIO balance_sheet (quarterly, 2024-12-31) — Total Debt: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2535000.00
VBIO income_statement (annual, 2024-12-31) — Total Expenses: 4476000.00
VBIO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 272000.00
VBIO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 168000.00
VBIO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
VBIO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -4476000.00
VBIO balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
VBIO balance_sheet (annual, 2024-12-31) — Work In Process: 5000.00
VBIO balance_sheet (quarterly, 2024-12-31) — Work In Process: 5000.00
VBIO balance_sheet (annual, 2024-12-31) — Working Capital: 2367000.00
VBIO income_statement (quarterly, 2025-03-31) — +Operating Expense: 1377000.00
VBIO income_statement (quarterly, 2025-03-31) — +Total Revenue: 0.00
VBIO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 438000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 13000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -41000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 48078000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
VBIO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 569368.00
VBIO income_statement (quarterly, 2025-03-31) — Basic EPS: -2.52
VBIO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 2002000.00
VBIO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -526000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 669000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 669000.00
VBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 82000.00
VBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -526000.00
VBIO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -829000.00
VBIO cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: -60000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 313000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 156000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Inventory: 0.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -2000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 0.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Payable: 313000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 469000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -24000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Receivables: 56000.00
VBIO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 443000.00
VBIO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: 56000.00
VBIO cash_flow (quarterly, 2025-03-31) — Changes In Cash: -1333000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3036000.00
VBIO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 20000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 253000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Current Assets: 1261000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 741000.00
VBIO cash_flow (quarterly, 2025-03-31) — Depreciation: 1000.00
VBIO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1000.00
VBIO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1000.00
VBIO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 569368.00
VBIO income_statement (quarterly, 2025-03-31) — Diluted EPS: -2.52
VBIO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -1502000.00
VBIO income_statement (quarterly, 2025-03-31) — EBIT: -1373000.00
VBIO income_statement (quarterly, 2025-03-31) — EBITDA: -1372000.00
VBIO cash_flow (quarterly, 2025-03-31) — End Cash Position: 669000.00
VBIO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 82000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Finished Goods: 178000.00
VBIO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -1415000.00
VBIO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 1042000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 2226000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 13000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 159000.00
VBIO income_statement (quarterly, 2025-03-31) — Gross Profit: 50000.00
VBIO income_statement (quarterly, 2025-03-31) — Interest Expense: 0.00
VBIO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 0.00
VBIO income_statement (quarterly, 2025-03-31) — Interest Income: 4000.00
VBIO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 4000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Inventories Adjustments Allowances: -338000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Inventory: 306000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3036000.00
VBIO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -526000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 11000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income: -1502000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -1502000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -1373000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -129000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -1502000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -1373000.00
VBIO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -1373000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -1502000.00
VBIO cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -526000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Interest Income: 4000.00
VBIO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 4000.00
VBIO cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -27000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Net PPE: 118000.00
VBIO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
VBIO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 810000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 170000.00
VBIO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -1372000.00
VBIO income_statement (quarterly, 2025-03-31) — Normalized Income: -1373000.00
VBIO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -889000.00
VBIO income_statement (quarterly, 2025-03-31) — Operating Income: -1377000.00
VBIO income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
VBIO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 705641.00
VBIO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 273000.00
VBIO income_statement (quarterly, 2025-03-31) — Other Gand A: 1042000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 2226000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 2000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Other Properties: 148000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Payables: 488000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 741000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
VBIO income_statement (quarterly, 2025-03-31) — Pretax Income: -1373000.00
VBIO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 109000.00
VBIO cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: 0.00
VBIO cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -526000.00
VBIO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
VBIO balance_sheet (quarterly, 2025-03-31) — Raw Materials: 461000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Receivables: 13000.00
VBIO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 20000.00
VBIO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1000.00
VBIO income_statement (quarterly, 2025-03-31) — Research And Development: 335000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -45043000.00
VBIO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 179000.00
VBIO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 1042000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Share Issued: 705641.00
VBIO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 100000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3036000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 810000.00
VBIO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
VBIO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Assets: 3777000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3036000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3036000.00
VBIO income_statement (quarterly, 2025-03-31) — Total Expenses: 1377000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 741000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2516000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
VBIO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -1377000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 50000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Work In Process: 5000.00
VBIO balance_sheet (quarterly, 2025-03-31) — Working Capital: 520000.00
VBIO income_statement (quarterly, 2025-06-30) — +Operating Expense: 1988000.00
VBIO income_statement (quarterly, 2025-06-30) — +Total Revenue: 86000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 234000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 13000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -42000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 50661000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Allowance For Doubtful Accounts Receivable: 0.00
VBIO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 881294.00
VBIO income_statement (quarterly, 2025-06-30) — Basic EPS: -2.19
VBIO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 669000.00
VBIO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -20000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1184000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1184000.00
VBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 2362000.00
VBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -20000.00
VBIO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -1887000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -204000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 197000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Inventory: 36000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 0.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 0.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Payable: -204000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -7000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -89000.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Receivables: 0.00
VBIO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -4000.00
VBIO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 0.00
VBIO cash_flow (quarterly, 2025-06-30) — Changes In Cash: 515000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3687000.00
VBIO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 32000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 333000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Current Assets: 1842000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 821000.00
VBIO cash_flow (quarterly, 2025-06-30) — Depreciation: 1000.00
VBIO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1000.00
VBIO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1000.00
VBIO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 881294.00
VBIO income_statement (quarterly, 2025-06-30) — Diluted EPS: -2.19
VBIO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -1931000.00
VBIO income_statement (quarterly, 2025-06-30) — EBIT: -1934000.00
VBIO income_statement (quarterly, 2025-06-30) — EBITDA: -1933000.00
VBIO cash_flow (quarterly, 2025-06-30) — End Cash Position: 1184000.00
VBIO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 2362000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Finished Goods: 156000.00
VBIO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1847000.00
VBIO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 907000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 2243000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 13000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 162000.00
VBIO income_statement (quarterly, 2025-06-30) — Gross Profit: 54000.00
VBIO income_statement (quarterly, 2025-06-30) — Interest Income: 3000.00
VBIO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 3000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Inventories Adjustments Allowances: -338000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Inventory: 283000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3687000.00
VBIO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -20000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 14000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Income: -1931000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -1931000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -1931000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -1931000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -1931000.00
VBIO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -2060000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -1931000.00
VBIO cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -17000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Interest Income: 3000.00
VBIO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 3000.00
VBIO cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -131000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Net PPE: 120000.00
VBIO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1444000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 301000.00
VBIO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -1933000.00
VBIO income_statement (quarterly, 2025-06-30) — Normalized Income: -1931000.00
VBIO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -1827000.00
VBIO income_statement (quarterly, 2025-06-30) — Operating Income: -1934000.00
VBIO income_statement (quarterly, 2025-06-30) — Operating Revenue: 94000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 965899.00
VBIO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 74000.00
VBIO income_statement (quarterly, 2025-06-30) — Other Gand A: 907000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 2243000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 2000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Other Properties: 148000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Payables: 294000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 627000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 194000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
VBIO balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 288000.00
VBIO income_statement (quarterly, 2025-06-30) — Pretax Income: -1931000.00
VBIO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 0.00
VBIO cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 0.00
VBIO cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -17000.00
VBIO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Raw Materials: 460000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Receivables: 13000.00
VBIO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 32000.00
VBIO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1000.00
VBIO income_statement (quarterly, 2025-06-30) — Research And Development: 655000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -46975000.00
VBIO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 426000.00
VBIO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1333000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Share Issued: 965899.00
VBIO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 176000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 3687000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1444000.00
VBIO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
VBIO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Assets: 4508000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 3687000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 3687000.00
VBIO income_statement (quarterly, 2025-06-30) — Total Expenses: 2020000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 821000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 2666000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
VBIO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -1934000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 60000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Work In Process: 5000.00
VBIO balance_sheet (quarterly, 2025-06-30) — Working Capital: 1021000.00
VBIO income_statement (quarterly, 2025-09-30) — +Operating Expense: 2338000.00
VBIO income_statement (quarterly, 2025-09-30) — +Total Revenue: 146000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 465000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 19000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -12000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 55206000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 1320778.00
VBIO income_statement (quarterly, 2025-09-30) — Basic EPS: -1.97
VBIO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 1184000.00
VBIO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -10000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3450000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 3450000.00
VBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 4272000.00
VBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -10000.00
VBIO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1996000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 231000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -327000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Inventory: 49000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: -21000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 0.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Payable: 231000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -96000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 95000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -6000.00
VBIO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 21000.00
VBIO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -6000.00
VBIO cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2266000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Common Stock: 2000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5591000.00
VBIO cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 429000.00
VBIO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 291000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 100000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Current Assets: 3740000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 638000.00
VBIO cash_flow (quarterly, 2025-09-30) — Depreciation: 0.00
VBIO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 0.00
VBIO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 1320778.00
VBIO income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.97
VBIO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2642000.00
VBIO income_statement (quarterly, 2025-09-30) — EBIT: -2483000.00
VBIO income_statement (quarterly, 2025-09-30) — EBITDA: -2483000.00
VBIO cash_flow (quarterly, 2025-09-30) — End Cash Position: 3450000.00
VBIO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 4272000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Finished Goods: 109000.00
VBIO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -2006000.00
VBIO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Ppe: -117000.00
VBIO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 1065000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 2243000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 19000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 24000.00
VBIO income_statement (quarterly, 2025-09-30) — Gross Profit: -145000.00
VBIO income_statement (quarterly, 2025-09-30) — Interest Income: 4000.00
VBIO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 4000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Inventories Adjustments Allowances: -568000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Inventory: 4000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 5591000.00
VBIO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -10000.00
VBIO cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 4182000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 24000.00
VBIO cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 429000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Income: -2596000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2642000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2596000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2596000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2596000.00
VBIO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2596000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2596000.00
VBIO cash_flow (quarterly, 2025-09-30) — Net Intangibles Purchase And Sale: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Net Interest Income: 4000.00
VBIO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 4000.00
VBIO cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 90000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Net PPE: 12000.00
VBIO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -10000.00
VBIO cash_flow (quarterly, 2025-09-30) — Net Preferred Stock Issuance: 3753000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 3348000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 211000.00
VBIO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -2366000.00
VBIO income_statement (quarterly, 2025-09-30) — Normalized Income: -2479000.00
VBIO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1996000.00
VBIO income_statement (quarterly, 2025-09-30) — Operating Income: -2483000.00
VBIO income_statement (quarterly, 2025-09-30) — Operating Revenue: 161000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 1662921.00
VBIO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 223000.00
VBIO income_statement (quarterly, 2025-09-30) — Other Gand A: 1065000.00
VBIO income_statement (quarterly, 2025-09-30) — Other Income Expense: -117000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 2243000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 23000.00
VBIO income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 10000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Payables: 538000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 638000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Preferred Stock Dividends: 36000.00
VBIO cash_flow (quarterly, 2025-09-30) — Preferred Stock Issuance: 3753000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 44000.00
VBIO income_statement (quarterly, 2025-09-30) — Pretax Income: -2596000.00
VBIO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
VBIO cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 230000.00
VBIO cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: 0.00
VBIO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -10000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Raw Materials: 458000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Receivables: 19000.00
VBIO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 291000.00
VBIO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Research And Development: 858000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -49617000.00
VBIO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 415000.00
VBIO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 1480000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Share Issued: 1662921.00
VBIO income_statement (quarterly, 2025-09-30) — Special Income Charges: -117000.00
VBIO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 139000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5591000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 3348000.00
VBIO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
VBIO balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 0.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Assets: 6229000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5591000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5591000.00
VBIO income_statement (quarterly, 2025-09-30) — Total Expenses: 2629000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 638000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2489000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
VBIO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -2483000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 73000.00
VBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -117000.00
VBIO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -117000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Work In Process: 5000.00
VBIO balance_sheet (quarterly, 2025-09-30) — Working Capital: 3102000.00
VBIO income_statement (annual, 2025-12-31) — +Operating Expense: 7898000.00
VBIO income_statement (quarterly, 2025-12-31) — +Operating Expense: 2016000.00
VBIO income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
VBIO income_statement (quarterly, 2025-12-31) — +Total Revenue: -302000.00
VBIO balance_sheet (annual, 2025-12-31) — Accounts Payable: 264000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 264000.00
VBIO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -15000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -15000.00
VBIO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 69392000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 69392000.00
VBIO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 143000.00
VBIO balance_sheet (annual, 2025-12-31) — Assets Held For Sale Current: 15000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Assets Held For Sale Current: 15000.00
VBIO income_statement (annual, 2025-12-31) — Basic Average Shares: 1155531.00
VBIO income_statement (annual, 2025-12-31) — Basic EPS: -7.84
VBIO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2002000.00
VBIO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 3450000.00
VBIO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 3457000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 3457000.00
VBIO cash_flow (annual, 2025-12-31) — Capital Expenditure: -581000.00
VBIO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -25000.00
VBIO balance_sheet (annual, 2025-12-31) — Capital Stock: 2000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2000.00
VBIO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 12645000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 12645000.00
VBIO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 12645000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 12645000.00
VBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 18347000.00
VBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 11631000.00
VBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -705000.00
VBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -149000.00
VBIO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -6619000.00
VBIO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1907000.00
VBIO cash_flow (annual, 2025-12-31) — Cash From Discontinued Operating Activities: -380000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Account Payable: 139000.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -201000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: 235000.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: 209000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 0.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 23000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 0.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 0.00
VBIO cash_flow (annual, 2025-12-31) — Change In Payable: 139000.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Payable: -201000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 374000.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 8000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 78000.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 96000.00
VBIO cash_flow (annual, 2025-12-31) — Change In Working Capital: 452000.00
VBIO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -8000.00
VBIO cash_flow (annual, 2025-12-31) — Changes In Cash: 10643000.00
VBIO cash_flow (quarterly, 2025-12-31) — Changes In Cash: 9195000.00
VBIO balance_sheet (annual, 2025-12-31) — Common Stock: 2000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Common Stock: 2000.00
VBIO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 16797000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 16797000.00
VBIO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 2337000.00
VBIO cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
VBIO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 196000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 196000.00
VBIO balance_sheet (annual, 2025-12-31) — Current Assets: 13006000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Current Assets: 13006000.00
VBIO balance_sheet (annual, 2025-12-31) — Current Liabilities: 646000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 646000.00
VBIO cash_flow (annual, 2025-12-31) — Depreciation: 5000.00
VBIO cash_flow (quarterly, 2025-12-31) — Depreciation: 3000.00
VBIO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5000.00
VBIO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 3000.00
VBIO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5000.00
VBIO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 3000.00
VBIO balance_sheet (annual, 2025-12-31) — Derivative Product Liabilities: 292000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Derivative Product Liabilities: 292000.00
VBIO income_statement (annual, 2025-12-31) — Diluted Average Shares: 1155531.00
VBIO income_statement (annual, 2025-12-31) — Diluted EPS: -7.84
VBIO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -8878000.00
VBIO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -2802000.00
VBIO income_statement (annual, 2025-12-31) — EBIT: -7847000.00
VBIO income_statement (quarterly, 2025-12-31) — EBIT: -1924000.00
VBIO income_statement (annual, 2025-12-31) — EBITDA: -7842000.00
VBIO income_statement (quarterly, 2025-12-31) — EBITDA: -1921000.00
VBIO cash_flow (annual, 2025-12-31) — End Cash Position: 12645000.00
VBIO cash_flow (quarterly, 2025-12-31) — End Cash Position: 12645000.00
VBIO cash_flow (annual, 2025-12-31) — Financing Cash Flow: 18347000.00
VBIO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 11631000.00
VBIO cash_flow (annual, 2025-12-31) — Free Cash Flow: -7580000.00
VBIO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2312000.00
VBIO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -28000.00
VBIO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 28000.00
VBIO income_statement (annual, 2025-12-31) — General And Administrative Expense: 4767000.00
VBIO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1753000.00
VBIO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2243000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2243000.00
VBIO balance_sheet (annual, 2025-12-31) — Gross PPE: 16113000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 16113000.00
VBIO income_statement (annual, 2025-12-31) — Interest Expense: 146000.00
VBIO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 146000.00
VBIO income_statement (annual, 2025-12-31) — Interest Income: 23000.00
VBIO income_statement (quarterly, 2025-12-31) — Interest Income: 12000.00
VBIO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 23000.00
VBIO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 12000.00
VBIO balance_sheet (annual, 2025-12-31) — Invested Capital: 23251000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 23251000.00
VBIO cash_flow (annual, 2025-12-31) — Investing Cash Flow: -705000.00
VBIO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -149000.00
VBIO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 18546000.00
VBIO cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 11871000.00
VBIO balance_sheet (annual, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
VBIO balance_sheet (quarterly, 2025-12-31) — Liabilities Heldfor Sale Non Current: 0.00
VBIO balance_sheet (annual, 2025-12-31) — Long Term Debt: 6454000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 6454000.00
VBIO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6454000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 6454000.00
VBIO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 12656000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 12656000.00
VBIO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 2337000.00
VBIO cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
VBIO income_statement (annual, 2025-12-31) — Net Income: -8878000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Income: -2849000.00
VBIO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -8878000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -2802000.00
VBIO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -7993000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1964000.00
VBIO income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: -885000.00
VBIO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -8878000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -2849000.00
VBIO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -7993000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1964000.00
VBIO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -7993000.00
VBIO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1964000.00
VBIO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -8878000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -2849000.00
VBIO cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -543000.00
VBIO cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
VBIO income_statement (annual, 2025-12-31) — Net Interest Income: -123000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Interest Income: -134000.00
VBIO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -124000.00
VBIO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -123000.00
VBIO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -134000.00
VBIO cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -308000.00
VBIO cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -240000.00
VBIO balance_sheet (annual, 2025-12-31) — Net PPE: 16098000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Net PPE: 16098000.00
VBIO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -38000.00
VBIO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -25000.00
VBIO cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: 16209000.00
VBIO cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: 11871000.00
VBIO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 14554000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 14554000.00
VBIO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 136000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 136000.00
VBIO income_statement (annual, 2025-12-31) — Normalized EBITDA: -7870000.00
VBIO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -2066000.00
VBIO income_statement (annual, 2025-12-31) — Normalized Income: -8021000.00
VBIO income_statement (quarterly, 2025-12-31) — Normalized Income: -2109000.00
VBIO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -6999000.00
VBIO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2287000.00
VBIO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -28000.00
VBIO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -145000.00
VBIO income_statement (annual, 2025-12-31) — Operating Income: -7898000.00
VBIO income_statement (quarterly, 2025-12-31) — Operating Income: -1975000.00
VBIO income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
VBIO income_statement (quarterly, 2025-12-31) — Operating Revenue: -325000.00
VBIO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2525778.00
VBIO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2525778.00
VBIO balance_sheet (annual, 2025-12-31) — Other Current Assets: 346000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 346000.00
VBIO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 6000.00
VBIO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 6000.00
VBIO income_statement (annual, 2025-12-31) — Other Gand A: 4767000.00
VBIO income_statement (quarterly, 2025-12-31) — Other Gand A: 1753000.00
VBIO income_statement (annual, 2025-12-31) — Other Income Expense: 28000.00
VBIO income_statement (quarterly, 2025-12-31) — Other Income Expense: 145000.00